Hydroxyacid Oxidase-1/HAO-1 Antibody [Alexa Fluor® 594]

• Reactivity: Hu
• Applications: WB
• Clonality: Polyclonal
• Host: Sheep
• Conjugate: Alexa Fluor 594

Hydroxyacid Oxidase-1/HAO-1 Antibody [Alexa Fluor® 594] Summary

• Immunogen: E. coli-derived recombinant human Hydroxyacid Oxidase-1/HAO-1
  Leu2-Ile370
  Accession # Q9UJM8
• Specificity: Detects human Hydroxyacid Oxidase-1/HAO-1 in direct ELISAs and Western blots.
• Isotype: IgG
• Clonality: Polyclonal
• Host: Sheep
• Purity Statement: Antigen Affinity-purified

Applications/Dilutions

• Dilutions:
  • Western Blot

Packaging, Storage & Formulations

• Storage: Protect from light. Do not freeze. 12 months from date of receipt, 2 to 8 °C as supplied
• Buffer: Supplied 0.2mg/ml in 1X PBS with RDF1 and 0.09% Sodium Azide

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for Hydroxyacid Oxidase-1/HAO-1 Antibody [Alexa Fluor® 594]

• (S)-2-hydroxy-acid oxidase
• EC 1.1.3.15
• Glycolate oxidase
• GOX
• GOX1MGC142227
• GOXMGC142225
• HAO1
• HAO-1
• HAOX1
• hydroxyacid oxidase (glycolate oxidase) 1
• hydroxyacid oxidase 1
• Hydroxyacid Oxidase1
• Hydroxyacid Oxidase-1

Background

Glycolate oxidase is a member of the superfamily of the alpha ‑hydroxy acid oxidases (HAO), enzymes that are present in both plants and animals (1). It catalyzes the FMN-mediated oxidation of glycolate to glyoxylate and glyoxylate to oxalate with reduction of oxygen to hydrogen peroxide (2, 3). The co‑factor, FMN, is tightly bound but not covalently linked to the protein. In humans and other vertebrates, HAOs are found primarily in the peroxisomes of liver, kidney, and pancreas. Three HAOs have been identified in humans (4). HAO-1 is most highly expressed in liver and pancreas and is most active on two-carbon substrates such as glycolate. HAO-2 is expressed in liver and kidney and has greater activity against long-chain alpha ‑hydroxy acid substrates such as 2‑hydroxypalmitate. HAO-3 is expressed primarily in the pancreas. Recently, HAO has been identified as a major contributor to hyperoxaluria, a disorder in which large deposits of calcium oxalate form kidney stones (5).

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.